BCG versus thiotepa in non-CIS, stage Ta, T1 bladder cancer: rationale and design of ECOG trial

Related Experiment Videos

¹Department of Urologic Oncology, Albany Medical College, New York.

Progress in Clinical and Biological Research

|January 1, 1989

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A compartment model to predict in vitro finite dose absorption of chemicals by human skin.

Chemosphere·2023

Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas.

Cancer·2001

The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: a comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2.

Cancer·1999

Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer.

The American journal of surgical pathology·1999

Correlation of p34cdc2 cyclin-dependent kinase overexpression, CD44s downregulation, and HER-2/neu oncogene amplification with recurrence in prostatic adenocarcinomas.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998

Intravenous lidocaine speeds the return of bowel function, decreases postoperative pain, and shortens hospital stay in patients undergoing radical retropubic prostatectomy.

Anesthesia and analgesia·1998

See all related articles